Medical and procedural treatment of androgenetic alopecia - Where are we?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 37591565.
- Also identified by DOI 10.1016/j.jaad.2023.05.004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Novel medical and procedural options for androgenetic alopecia have arrived. Low-dose oral minoxidil has made its clinical debut, while data on spironolactone, finasteride, and nutritional supplements have advanced. Minimally invasive technological advancements include photobiomodulation and platelet-rich plasma. Within hair transplantation, follicular unit extraction and robotics are now at the clinicians' fingertips.
Medical subject headings
- Alopecia
- Finasteride